Editorial

You have full text access to this OnlineOpen article

Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis

  1. Berent Prakken1,*,
  2. Salvatore Albani2

Article first published online: 30 JAN 2007

DOI: 10.1002/art.22317

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 56, Issue 2, pages 389–392, February 2007

Additional Information

How to Cite

Prakken, B. and Albani, S. (2007), Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis. Arthritis & Rheumatism, 56: 389–392. doi: 10.1002/art.22317

Author Information

  1. 1

    University Medical Center Utrecht, and Wilhelmina Children's Hospital, Utrecht, The Netherlands, and EUREKA Institute for Translational Medicine, Syracuse, Italy

  2. 2

    EUREKA Institute for Translational Medicine, Syracuse, Italy, University of California, San Diego, and Androclus Therapeutics, San Diego, California

*Department of Pediatric Immunology KC.03.063.0, University Medical Center Utrecht, PO Box 85090, 3508 GA Utrecht, The Netherlands

Publication History

  1. Issue published online: 30 JAN 2007
  2. Article first published online: 30 JAN 2007
  3. Manuscript Accepted: 29 SEP 2006
  4. Manuscript Received: 10 AUG 2006

Funded by

  • Fifth Framework Program “HSP for therapy,”
  • Dutch Arthritis Foundation
  • Dutch Organization for Scientific Research
  • NIH. Grant Numbers: 5P50-AR-44850-04, N01-AR-9-2241, 2R01-AI-41721-05, 1R01-AR-48084-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (51K)

First page of article

First page of Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis
View Full Article (HTML) Get PDF (51K)